4VR-26972-21294
4 vaccinations
10 coded responses
32 check-ins
9 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 365 / AL
- Registered
- 2021-02-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-13
Dose 1 — Pfizer-BioNTech
-
2021-02-14
Registered in v-safe
-
2021-02-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-27
-
2021-03-06
Dose 2 — Pfizer-BioNTech
-
2021-03-06
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2021-03-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-09
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-20
-
2021-03-27
Survey response — day 21, dose 2MedDRA: Chills, Cough, Fatigue, Headache, Nasal congestion, Pyrexia, Respiratory tract congestion, Sinus congestion — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Fever, chills, headache, nasal, sinus, & chest congestion, dry cough, tiredMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-03
- 2021-04-10
-
2021-04-17
Survey response — day 42, dose 2MedDRA: Visual impairment — Feeling: GoodFree text: My eyesight has worsened significantly over the past month, close up and distant.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-09-04
-
2021-11-02
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2022-06-01
Dose 4 — Pfizer-BioNTech
-
2022-06-02
Survey response — days 1–6 daily, dose 4MedDRA: Dizziness, Headache — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Felling faint, severe headacheMedDRA releases: 2024-11 · check-in free text available
-
2022-06-03
Survey response — days 1–6 daily, dose 4MedDRA: Pruritus — Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tiredness, Abdominal painFree text: Itching in areas other than the injection siteMedDRA releases: 2024-11 · check-in free text available
-
2022-06-04
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2022-06-07
Survey response — days 1–6 daily, dose 4MedDRA: Dyspepsia, Flatulence — Feeling: Fair · Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Indigestion, gasMedDRA releases: 2024-11 · check-in free text available
-
2022-06-10
Survey response — day 7, dose 4MedDRA: Dyspepsia — Feeling: Fair · Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: IndigestionMedDRA releases: 2024-11 · check-in free text available
- 2022-06-17
-
2022-06-22
Survey response — day 21, dose 4MedDRA: Fatigue, Gastrooesophageal reflux disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Acid reflux, gas, exhaustionMedDRA releases: 2024-11 · check-in free text available
- 2022-06-29
-
2022-07-08
Survey response — day 35, dose 4MedDRA: Vision blurred — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Blurred visionMedDRA releases: 2024-11 · check-in free text available
- 2022-07-15
-
2022-08-31
Survey response — 3 months, dose 4MedDRA: Cardiac amyloidosis, Fatigue, Gastrooesophageal reflux disease, Hypertension, Palpitations, Visual impairment — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Stiff Heart Syndrome, High Blood Pressure, worsening GERD, Worsening eyesight, fatigue, Daily heart PalpitationsMedDRA releases: 2024-11 · check-in free text available
-
2022-08-31
Report sent to call center — 3 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-09-01
-
2023-06-01
Survey response — 12 months, dose 4MedDRA: Cardiac failure congestive, Hypertension, Muscle spasms, Plantar fasciitis, Tinnitus, Visual impairment — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
- 2023-06-01
- 2023-06-02
- 2023-06-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-13 | Pfizer-BioNTech | |
| 2 | 2021-03-06 | Pfizer-BioNTech | |
| 3 | 2021-11-02 | Pfizer-BioNTech | Flu |
| 4 | 2022-06-01 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 6 — day 21, dose 2
Symptoms: Fever, chills, headache, nasal, sinus, & chest congestion, dry cough, tired
Release 7 — day 42, dose 2
Symptoms: My eyesight has worsened significantly over the past month, close up and distant.
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Felling faint, severe headache
Systemic reaction (other): Itching in areas other than the injection site
Systemic reaction (other): Indigestion, gas
Release 12 — day 7, dose 4
Systemic reaction (other): Indigestion
Release 12 — day 21, dose 4
Symptoms: Acid reflux, gas, exhaustion
Release 12 — day 35, dose 4
Symptoms: Blurred vision
Release 12 — 3 months, dose 4
Symptoms: Stiff Heart Syndrome, High Blood Pressure, worsening GERD, Worsening eyesight, fatigue, Daily heart Palpitations
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cardiac amyloidosis | · | · | ✓ |
| SD | Cardiac failure congestive | · | · | ✓ |
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Gastrooesophageal reflux disease | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hypertension | · | · | ✓ |
| SD | Muscle spasms | · | · | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Palpitations | · | · | ✓ |
| SD | Plantar fasciitis | · | · | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Sinus congestion | ✓ | ✓ | ✓ |
| SD | Tinnitus | · | · | ✓ |
| SD | Vision blurred | · | · | ✓ |
| SD | Visual impairment | ✓ | ✓ | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Dyspepsia | · | · | ✓ |
| SRO | Flatulence | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Pruritus | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release